← All trials
NCT03113084
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2017
- Primary completion
- Feb 28, 2018
- Completion date
- Apr 30, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 38
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- União Química Farmacêutica Nacional S/ALead sponsor
- União Química Farmacêutica Nacional S/AStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.